Kenshiro Takemoto

11PUBLICATIONS
18CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 06, 2026
RIOK2 Promotes Clear Cell Renal Cell Carcinoma Progression Through Cell Cycle Regulation.

|Jul 23, 2026
External Validation of Prognostic Models for Nonmetastatic Clear Cell Renal Cell Carcinoma in a Japanese Cohort: Evaluation of Predictive Performance.

|Jul 01, 2026
Clinical and genomic characteristics of primary resistant disease to first-line immuno-oncology plus VEGFR inhibitor therapy in metastatic renal cell carcinoma.

|Feb 26, 2026
KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma.

Yoshinori Nakano, Yohei Sekino, Go Kobayashi

|Jan 26, 2026
Genomic and Clinical Impact of Smoking on Therapeutic Outcomes in Prostate Cancer: A Public Databases Analysis.

Tomoya Hatayama, Yohei Sekino, Go Kobayashi

|Nov 29, 2025
Crucial Contribution of BACH1 to Bladder Cancer Progression via Upregulating Epithelial-Mesenchymal Transition Pathway.

Tomoya Hatayama, Kenshiro Takemoto, Kohei Kobatake

Pageof 2

Frequent Collaborators

11 joint publications

Nobuyuki Hinata

9 joint publications

Kohei Kobatake

7 joint publications

Miki Naito

7 joint publications

Shunsuke Miyamoto